耐多药结核病-话题@MedSci

#耐多药结核病#

20篇内容 | 1924人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2183825, encodeId=492a218382569, content=<a href='/topic/show?id=f5f955419b0' target=_blank style='color:#2F92EE;'>#抗生素#</a> <a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=你体内的强大战斗力——Science子刊揭示肠道微生物组如何响应并适应抗生素暴露, objectType=article, longId=810831, objectId=29af81083121, topicUrl=null, isHasObj=0, objectCover=https://msimg.bioon.com/bioon-com/20240125/1706147144969_8827638.jpg, objectUrl=/article/show_article.do?id=29af81083121, replyNumber=0, likeNumber=94, createdTime=2024-01-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1458412, encodeId=15d11458412d6, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=美国加利佛尼亚州贝达喹啉治疗耐多药结核病对QTc间期的影响, objectType=article, longId=208528, objectId=6e872085287e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e872085287e, replyNumber=0, likeNumber=81, createdTime=2021-03-18, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e872085287e, moduleTitle=美国加利佛尼亚州贝达喹啉治疗耐多药结核病对QTc间期的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e872085287e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458411, encodeId=e3c71458411d0, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=Eur Respir J：贝达喹啉 VS贝达喹啉-达拉米尼联合治疗耐多药结核病的效果, objectType=article, longId=192363, objectId=4e1e19236383, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e1e19236383, replyNumber=0, likeNumber=101, createdTime=2020-04-17, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e1e19236383, moduleTitle=Eur Respir J：贝达喹啉 VS贝达喹啉-达拉米尼联合治疗耐多药结核病的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e1e19236383)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458410, encodeId=6057145841057, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=含贝达奎宁的短期疗程方案治疗耐多药结核病的成本效益分析, objectType=article, longId=191963, objectId=c76e19196362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c76e19196362, replyNumber=0, likeNumber=0, createdTime=2020-04-12, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c76e19196362, moduleTitle=含贝达奎宁的短期疗程方案治疗耐多药结核病的成本效益分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c76e19196362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458409, encodeId=ac49145840970, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=Respir Investig：贝达奎林治疗耐多药结核病的效果和安全性, objectType=article, longId=191941, objectId=7162191941b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7162191941b9, replyNumber=0, likeNumber=104, createdTime=2020-04-11, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7162191941b9, moduleTitle=Respir Investig：贝达奎林治疗耐多药结核病的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7162191941b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458408, encodeId=72b41458408c0, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=Lancet Respir Med：耐多药结核病治疗过程中不良事件的发生, objectType=article, longId=191901, objectId=0b6c1919011b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b6c1919011b, replyNumber=0, likeNumber=115, createdTime=2020-04-11, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b6c1919011b, moduleTitle=Lancet Respir Med：耐多药结核病治疗过程中不良事件的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b6c1919011b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458407, encodeId=056d145840e8e, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=贝达奎宁治疗耐多药结核病的美国经验 , objectType=article, longId=191820, objectId=b450191820c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b450191820c1, replyNumber=0, likeNumber=63, createdTime=2020-04-10, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b450191820c1, moduleTitle=贝达奎宁治疗耐多药结核病的美国经验 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b450191820c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458406, encodeId=025614584068f, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=耐多药结核病治疗方案知多少？, objectType=article, longId=190636, objectId=5964190636b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5964190636b5, replyNumber=0, likeNumber=95, createdTime=2020-03-25, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5964190636b5, moduleTitle=耐多药结核病治疗方案知多少？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5964190636b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458405, encodeId=4e7114584058b, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=耐多药结核病短程治疗中国专家共识, objectType=article, longId=163329, objectId=a8f31633294a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8f31633294a, replyNumber=0, likeNumber=71, createdTime=2019-04-01, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8f31633294a, moduleTitle=耐多药结核病短程治疗中国专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8f31633294a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458404, encodeId=d144145840413, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=荐读｜我国完成耐多药结核病全解析，14省区完成进口抗癌药联合议价，高脂肪饮食对肝脏“危害持久”！, objectType=article, longId=153582, objectId=3dde1535822e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dde1535822e, replyNumber=0, likeNumber=74, createdTime=2018-11-17, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dde1535822e, moduleTitle=荐读｜我国完成耐多药结核病全解析，14省区完成进口抗癌药联合议价，高脂肪饮食对肝脏“危害持久”！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dde1535822e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458403, encodeId=d39a1458403d0, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=我国完成耐多药结核病全解析, objectType=article, longId=153537, objectId=b59415353e2e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b59415353e2e, replyNumber=0, likeNumber=67, createdTime=2018-11-16, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b59415353e2e, moduleTitle=我国完成耐多药结核病全解析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b59415353e2e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458402, encodeId=27e51458402e2, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=Lancet Infect Dis：耐多药结核病疫情的“元凶”原来是它, objectType=article, longId=84659, objectId=7fe684659b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fe684659b5, replyNumber=0, likeNumber=85, createdTime=2016-12-20, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fe684659b5, moduleTitle=Lancet Infect Dis：耐多药结核病疫情的“元凶”原来是它, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fe684659b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458401, encodeId=9a2e1458401d6, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=Tuberc Respir Dis：耐多药结核病治疗, objectType=article, longId=82876, objectId=1b6b828e6a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b6b828e6a6, replyNumber=0, likeNumber=73, createdTime=2016-11-24, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b6b828e6a6, moduleTitle=Tuberc Respir Dis：耐多药结核病治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b6b828e6a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458400, encodeId=bd7d1458400f6, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=Eur Respir J：用美罗培南/克拉维酸治疗耐多药结核病和超级耐多药结核病的有效性、安全性分析, objectType=article, longId=82819, objectId=913e8281947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=913e8281947, replyNumber=0, likeNumber=85, createdTime=2016-11-23, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=913e8281947, moduleTitle=Eur Respir J：用美罗培南/克拉维酸治疗耐多药结核病和超级耐多药结核病的有效性、安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=913e8281947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458399, encodeId=f30e145839957, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=Clin Infect Dis：积极治疗可降低耐多药结核病治疗成功后的复发风险, objectType=article, longId=82818, objectId=2e3182818c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e3182818c1, replyNumber=0, likeNumber=75, createdTime=2016-11-23, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e3182818c1, moduleTitle=Clin Infect Dis：积极治疗可降低耐多药结核病治疗成功后的复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e3182818c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458398, encodeId=d7341458398b7, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=Sci Rep：用Meltpro TB实验快速诊断耐多药结核病与超级耐多药结核病, objectType=article, longId=82761, objectId=fee282e6171, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fee282e6171, replyNumber=0, likeNumber=61, createdTime=2016-11-22, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fee282e6171, moduleTitle=Sci Rep：用Meltpro TB实验快速诊断耐多药结核病与超级耐多药结核病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fee282e6171)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458397, encodeId=0ef2145839efa, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=Int J Biol Sci：耐多药结核病新的血清诊断标志物, objectType=article, longId=82759, objectId=6fc782e59b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fc782e59b2, replyNumber=0, likeNumber=78, createdTime=2016-11-22, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fc782e59b2, moduleTitle=Int J Biol Sci：耐多药结核病新的血清诊断标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fc782e59b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458396, encodeId=c721145839690, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=儿童与初治成人的耐多药结核病风险似乎相近, objectType=article, longId=33404, objectId=74e833404d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74e833404d4, replyNumber=0, likeNumber=76, createdTime=2014-04-17, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74e833404d4, moduleTitle=儿童与初治成人的耐多药结核病风险似乎相近, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74e833404d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458395, encodeId=4c051458395cc, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=The Lancet：全球每年约3.2万名儿童感染耐多药结核病, objectType=article, longId=32528, objectId=e0613252875, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0613252875, replyNumber=0, likeNumber=78, createdTime=2014-03-30, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0613252875, moduleTitle=The Lancet：全球每年约3.2万名儿童感染耐多药结核病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0613252875)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1458394, encodeId=182f14583949d, content=<a href='/topic/show?id=a39f803557a' target=_blank style='color:#2F92EE;'>#耐多药结核病#</a>, objectTitle=杨森旗下耐多药结核病药物Sirturo获CHMP上市许可推荐, objectType=article, longId=28549, objectId=6d582854901, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d582854901, replyNumber=0, likeNumber=93, createdTime=2013-12-27, rootId=0, userName=mgqwxj, userId=fa6e6064686, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d582854901, moduleTitle=杨森旗下耐多药结核病药物Sirturo获CHMP上市许可推荐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d582854901)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

耐多药结核病

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#抗生素# #耐多药结核病#

2024-01-25发表于上海

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

美国加利佛尼亚州贝达喹啉治疗耐多药结核病对QTc间期的影响

2021-03-18

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

Eur Respir J：贝达喹啉 VS贝达喹啉-达拉米尼联合治疗耐多药结核病的效果

2020-04-17

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

含贝达奎宁的短期疗程方案治疗耐多药结核病的成本效益分析

2020-04-12

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

Respir Investig：贝达奎林治疗耐多药结核病的效果和安全性

2020-04-11

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

Lancet Respir Med：耐多药结核病治疗过程中不良事件的发生

2020-04-11

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

贝达奎宁治疗耐多药结核病的美国经验

2020-04-10

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

耐多药结核病治疗方案知多少？

2020-03-25

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

耐多药结核病短程治疗中国专家共识

2019-04-01

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

荐读｜我国完成耐多药结核病全解析，14省区完成进口抗癌药联合议价，高脂肪饮食对肝脏“危害持久”！

2018-11-17

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

我国完成耐多药结核病全解析

2018-11-16

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

Lancet Infect Dis：耐多药结核病疫情的“元凶”原来是它

2016-12-20

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

Tuberc Respir Dis：耐多药结核病治疗

2016-11-24

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

Eur Respir J：用美罗培南/克拉维酸治疗耐多药结核病和超级耐多药结核病的有效性、安全性分析

2016-11-23

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

Clin Infect Dis：积极治疗可降低耐多药结核病治疗成功后的复发风险

2016-11-23

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

Sci Rep：用Meltpro TB实验快速诊断耐多药结核病与超级耐多药结核病

2016-11-22

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

Int J Biol Sci：耐多药结核病新的血清诊断标志物

2016-11-22

智者为医08 (审核中...)

前往app查看评论内容

#耐多药结核病#

儿童与初治成人的耐多药结核病风险似乎相近

2014-04-17

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

The Lancet：全球每年约3.2万名儿童感染耐多药结核病

2014-03-30

mgqwxj (审核中...)

前往app查看评论内容

#耐多药结核病#

杨森旗下耐多药结核病药物Sirturo获CHMP上市许可推荐

2013-12-27

科室
- - 订阅+
  - 更多科室
工具
服务